{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:20:58Z","timestamp":1790781658462,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["GS-13561"],"award-info":[{"award-number":["GS-13561"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["CRC-54205"],"award-info":[{"award-number":["CRC-54205"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-561391"],"award-info":[{"award-number":["PJT-561391"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cjca.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T06:24:57Z","timestamp":1611296697000},"page":"547-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-026X","authenticated-orcid":false,"given":"Haran","family":"Yogasundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Alhumaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Dzwiniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.9778\/cmajo.20150130","article-title":"The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis","volume":"4","author":"Tran","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cjca.2021.01.016_bib2","article-title":"Assessing the role of rare genetic variation in patients with heart failure","author":"Povysil","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib5","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of genetic diagnosis on patients with previously undiagnosed disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib9","first-page":"1","article-title":"Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy","volume":"11","author":"Pirruccello","year":"2020","journal-title":"Nata Commun"},{"key":"10.1016\/j.cjca.2021.01.016_bib10","first-page":"1706","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib11","first-page":"883","article-title":"Clinical features, diagnosis, and management of patients with Anderson-Fabry cardiomyopathy","volume":"33","author":"Yogasundaram","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003367","article-title":"Glycogen storage disease because of a prkag2 mutation causing severe biventricular hypertrophy and high-grade atrio-ventricular block","volume":"9","author":"Yogasundaram","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCRESAHA.113.300282","article-title":"Genetic cardiomyopathies causing heart failure","volume":"113","author":"Cahill","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2021.01.016_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003820","article-title":"Novel dominant-negative mutation in cardiac troponin I causes severe restrictive cardiomyopathy","volume":"10","author":"Shah","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib16","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009712","article-title":"Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies","volume":"13","author":"Aung","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2021.01.016_bib18","doi-asserted-by":"crossref","first-page":"M40","DOI":"10.1093\/eurheartj\/suz212","article-title":"Heart failure in dilated nonischaemic cardiomyopathy","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.cjca.2021.01.016_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/euhj.1997.0575","article-title":"Genotype\u2013phenotype correlations in familial hypertrophic cardiomyopathy: a comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes","volume":"19","author":"Charron","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib24","first-page":"3461","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of nonsarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002748","article-title":"Genetic testing for diagnosis of hypertrophic cardiomyopathy mimics: yield and clinical significance","volume":"13","author":"Hoss","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187948","article-title":"Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage","volume":"12","author":"Viswanathan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2021.01.016_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.hrthm.2011.08.009","article-title":"Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors","volume":"9","author":"Maron","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.01.016_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ejhg.2014.211","article-title":"Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects","volume":"23","author":"Wessels","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0735-1097(97)00433-6","article-title":"Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease","volume":"31","author":"Baig","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota 1975-1984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cvr\/cvy122","article-title":"Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"Bondue","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2021.01.016_bib35","article-title":"An evidence-based assessment of genes in dilated cardiomyopathy","author":"Jordan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.cjca.2021.01.016_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/eurjhf\/hfq093","article-title":"Prognostic impact of familial screening in dilated cardiomyopathy","volume":"12","author":"Moretti","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gim.2013.204","article-title":"The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing","volume":"16","author":"Pugh","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib42","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.01.016_bib43","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCEP.115.003534","article-title":"Left ventricular involvement in ARVD\/C","volume":"8","author":"Calkins","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2019.05.022","article-title":"Phenotypic manifestations of arrhythmogenic cardiomyopathy in children and adolescents","volume":"74","author":"DeWitt","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCGENETICS.113.000097","article-title":"Homozygous founder mutation in desmocollin-2 (DSC2) causes arrhythmogenic cardiomyopathy in the Hutterite population","volume":"6","author":"Gerull","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib48","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2021.01.016_bib50","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001780","article-title":"Novel mutation in FLNC (filamin C) causes familial restrictive cardiomyopathy","volume":"10","author":"Tucker","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrcardio.2016.207","article-title":"Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors","volume":"14","author":"Finsterer","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy","volume":"71","author":"van Waning","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jacc.2016.05.096","article-title":"Left ventricular noncompaction: a distinct genetic cardiomyopathy?","volume":"68","author":"Arbustini","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cca.2016.12.013","article-title":"Recent advancements in the molecular genetics of left ventricular noncompaction cardiomyopathy","volume":"465","author":"Dong","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cjca.2021.01.016_bib56","first-page":"1655","article-title":"Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians","volume":"30","author":"Chami","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cge.12971","article-title":"Novel founder mutation in French-Canadian families with Naxos disease","volume":"92","author":"Marino","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib58","article-title":"Advanced dilated cardiomyopathy in a patient with Hutterite limb-girdle muscular dystrophy","volume":"11","author":"Nichols","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib59","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ajmg.a.32245","article-title":"Clinical genetics and the Hutterite population: a review of mendelian disorders","volume":"146","author":"Boycott","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cjca.2021.01.016_bib60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jacbts.2018.12.001","article-title":"Characterization of a unique form of arrhythmic cardiomyopathy caused by recessive mutation in LEMD2","volume":"4","author":"Abdelfatah","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2021.01.016_bib61","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib62","doi-asserted-by":"crossref","first-page":"865170","DOI":"10.1155\/2012\/865170","article-title":"A\u00a0Dutch fanconi anemia FANCC founder mutation in Canadian Manitoba Mennonites","volume":"2012","author":"De Vries","year":"2012","journal-title":"Anemia"},{"key":"10.1016\/j.cjca.2021.01.016_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jmg.28.4.232","article-title":"Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone","volume":"28","author":"Kirkilionis","year":"1991","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib64","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.01.016_bib65","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"ACMG Professional Practice and Guidelines Committee. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib66","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181465","article-title":"Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy","volume":"12","author":"Mademont-Soler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2021.01.016_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cge.13024","article-title":"Clinical genetic testing in pediatric cardiomyopathy: is bigger better?","volume":"93","author":"Ouellette","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12471-019-1251-4","article-title":"Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice","volume":"27","author":"Christiaans","year":"2019","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001768","article-title":"A\u00a0comparison of whole genome sequencing to multigene panel testing in hypertrophic cardiomyopathy patients","volume":"10","author":"Cirino","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCGENETICS.113.000039","article-title":"Interpreting secondary cardiac disease variants in an exome cohort","volume":"6","author":"Ng","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib72","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002480","article-title":"Variant interpretation for dilated cardiomyopathy (DCM): refinement of the ACMG\/ClinGen guidelines for the DCM Precision Medicine Study","volume":"13","author":"Morales","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib74","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00246-016-1358-y","article-title":"Comprehensive versus targeted genetic testing in children with hypertrophic cardiomyopathy","volume":"37","author":"Bales","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib76","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCHEARTFAILURE.114.001666","article-title":"Novel mutation in exon 14 of the sarcomere gene MYH7 in familial left ventricular noncompaction with bicuspid aortic valve","volume":"7","author":"Basu","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-019-0688-9","article-title":"Is \u201clikely pathogenic\u201d really 90% likely? Reclassification data in ClinVar","volume":"11","author":"Harrison","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004835","article-title":"Machine-assisted genotype update system (MAGUS) for inherited cardiomyopathies","volume":"11","author":"Papoutsidakis","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2021.01.016_bib79","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/gim.2017.258","article-title":"CardioClassifier: disease-and gene-specific computational decision support for clinical genome interpretation","volume":"20","author":"Whiffin","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib80","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41431-019-0377-6","article-title":"Perceptions of genetic variant reclassification in patients with inherited cardiac disease","volume":"27","author":"Wong","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13073-019-0651-9","article-title":"Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series","volume":"11","author":"Taylor","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib82","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib83","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1016\/j.ijcard.2013.04.177","article-title":"A\u00a0case of lamin A\/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing","volume":"168","author":"Valtuille","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.01.016_bib85","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/CIRCULATIONAHA.107.746164","article-title":"Mutations in sarcomere protein genes in left ventricular noncompaction","volume":"117","author":"Klaassen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib86","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamacardio.2017.2352","article-title":"Role of genetic testing in inherited cardiovascular disease: a review","volume":"2","author":"Cirino","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007944","article-title":"Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy","volume":"14","author":"Xu","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jchf.2014.08.003","article-title":"Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression","volume":"3","author":"Ho","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.016_bib89","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.01.016_bib90","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.016_bib91","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaccas.2020.02.006","article-title":"The ever-expanding landscape of cardiomyopathies","volume":"2","author":"Asatryan","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.cjca.2021.01.016_bib92","first-page":"43","article-title":"Variant interpretation for dilated cardiomyopathy","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib93","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest noncanonical mechanisms for disease pathogenesis","volume":"113","author":"Te Riele","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2021.01.016_bib94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11886-020-1260-3","article-title":"Second hits in dilated cardiomyopathy","volume":"22","author":"Marstrand","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cjca.2021.01.016_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2017.79","article-title":"Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup","volume":"20","author":"Ko","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib97","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCULATIONAHA.118.035954","article-title":"Beyond the one gene\u2013one disease paradigm: complex genetics and pleiotropy in inheritable cardiac disorders","volume":"140","author":"Cerrone","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib98","article-title":"Prospective evaluation of the utility of whole exome sequencing in dilated cardiomyopathy","volume":"9","author":"Ramchand","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.01.016_bib99","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/npjgenmed.2015.12","article-title":"Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine","volume":"1","author":"Stavropoulos","year":"2016","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib100","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib101","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jgc4.1157","article-title":"Lessons learned from testing cardiac channelopathy and cardiomyopathy genes in individuals who died suddenly: a two-year prospective study in a large medical examiner\u2019s office with an in-house molecular genetics laboratory and genetic counseling services","volume":"29","author":"Williams","year":"2020","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.cjca.2021.01.016_bib102","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1002\/mgg3.593","article-title":"Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation","volume":"7","author":"Headrick","year":"2019","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing 2016 update (ACMG SF v2. 0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gr.183483.114","article-title":"Actionable exomic incidental findings in 6503 participants: challenges of variant classification","volume":"25","author":"Amendola","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.cjca.2021.01.016_bib105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajhg.2013.08.006","article-title":"National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project. Actionable, pathogenic incidental findings in 1,000 participants\u2019 exomes","volume":"93","author":"Dorschner","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cjca.2021.01.016_bib106","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/gim.2014.196","article-title":"Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics","volume":"17","author":"Jurgens","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135193","article-title":"Identification of medically actionable secondary findings in the 1000 genomes","volume":"10","author":"Olfson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2021.01.016_bib108","first-page":"1","article-title":"Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time","author":"van Rooij","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib109","first-page":"1812","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"22","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13073-019-0683-1","article-title":"Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels","volume":"11","author":"Kanavy","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib111","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.016_bib112","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtn.2017.12.012","article-title":"Gene therapy via trans-splicing for LMNA-related congenital muscular dystrophy","volume":"10","author":"Azibani","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cjca.2021.01.016_bib113","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient\u2019s iPSC-derived cardiomyocytes eliminates the electrophysiological and structural abnormalities","volume":"15","author":"Ben Jehuda","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.01.016_bib114","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/emmm.201202168","article-title":"Rescue of cardiomyopathy through U7sn RNA-mediated exon skipping in Mybpc3-targeted knock-in mice","volume":"5","author":"Gedicke-Hornung","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.cjca.2021.01.016_bib115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:39:46Z","timestamp":1778693986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X21000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0828282X21000544"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2021.01.016","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}